Companies: 10,795·Total market cap: $144.5T
Defence Therapeutics Inc.

Defence Therapeutics Inc.

DTC.CNCNQHealthcare● Active
$0.50
$-0.01(-1.96%)
Market Cap$28684985
P/E Ratio
52W High$0.93
52W Low$0.435

Defence Therapeutics Inc. (DTC.CN) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

dtc.cn · pe ratio · data through Jun 9, 2026

Core PE Ratio Metrics

Trailing 12 months · TTM

Insufficient PE history data (fewer than 3 valid fiscal years).

PE Ratio vs Peers

Biotechnology · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Defence Therapeutics Inc.
Defence Therapeutics Inc.You
DTC.CN
$29MN/A-$0.11
DIAGNOS Inc.
DIAGNOS Inc.
ADK.V
$22MN/A-$0.05
BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp.
BCT.TO
$8MN/A-$62.95
The Cannabist Company Holdings Inc.
The Cannabist Company Holdings Inc.
CBST.NE
$17MN/A-$0.23
Gemina Laboratories Ltd.
Gemina Laboratories Ltd.
GLAB.CN
$5MN/A-$0.06
Microbix Biosystems Inc.
Microbix Biosystems Inc.
MBX.TO
$39MN/A-$0.02
MedMira Inc.
MedMira Inc.
MIR.V
$42MN/A-$0.01

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Defence Therapeutics Inc. (DTC.CN) measures how much investors pay for each dollar of the company's trailing earnings. DTC.CN's current PE ratio of N/A is calculated by dividing its stock price of $0.50 by its TTM earnings per share of -$0.11.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.50 ÷ -$0.11 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

DTC.CN pe ratio · 6 questions

DTC.CN's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.50 and TTM EPS of -$0.11. Data sourced from Financial Modeling Prep via DTC.CN's SEC 10-K and 10-Q filings.

DTC.CN PE ratioWhat is DTC.CN PE ratioCurrent PE ratio of DTC.CNDTC.CN PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Defence Therapeutics Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09